DTaP/IPV/Hib+HepB vaccine (2025)

Concepts

• vaccines
• dtap/ipv/hib+hepb vaccine a contract
• (dtap/ipv/hib+hepb) vaccine
• dtap/ipv/hib+hepb vaccine (2025). contract
• hib+hepb
• vaccine
• hepatitis b
• dtap
• type b
• inactivated polio

Location

Lutterworth, UK

Geochart for 2 buyers and 1 suppliers

Secretary of State for Health & Social Care Acting as Part of the Crown Through UK Health Security Agency

Glaxosmithkline

+−

Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

Description

Contract for the supply of DTaP/IPV/Hib+HepB vaccine

Total Quantity or Scope

A contract for the supply of diptheria, tetanus, acellular pertussis, inactivated polio, Haemophilus influenzae type b, hepatitis B (DTaP/IPV/Hib+HepB) vaccine.Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.

Award Detail

Renewal Options

The contract has the option to be extended for up to an additional 24 months

Award Criteria

CPV Codes

• 33651600 - Vaccines

Indicators

• Options are available.

Other Information

Value — The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier. The contract is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.